Response to interleukin-6

pathway activity — cross-omics
GO:0070741Cross-omicsRNA → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Response to interleukin-6 pathway is significantly associated with the RNA expression of multiple genes, with the SCLC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are LILRB1, CD53, and TLR8, each associated with the pathway in up to 33 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Response to interleukin-6 activity versus LILRB1 in SCLC (Pearson r = 0.54).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
SCLCLILRB1 →+1.786+0.181<.001<.001333
KICHCD53 →+1.951+0.049<.001<.001333
LAMLTLR8 →+2.213+0.056<.001<.001332
SCLCCXorf21 →+1.081+0.124<.001<.001332
DLBCFGL2 →+1.782+0.064<.001<.001332
SKCMGPR65 →+0.998+0.041<.001<.001332
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0070741 vs LILRB1 — SCLC

Per-sample scatter of Response to interleukin-6 activity vs LILRB1 in SCLC.

Explore this scatter interactively →

Exploration